nav-left cat-right
cat-right

PharmaGap completes acute toxicity tests for lead ...

OTTAWA, May 17 /CNW Telbec/ – PharmaGap Inc. (TSX-V: GAP) (“PharmaGap” or “the Company”) today announced the formal completion of acute toxicity testing in mice for its lead cancer drug, PhG alpha 1. Testing took place in Ottawa at accredited facilities operated by the Institute of Biological Sciences, part of the National Research Council of Canada, under the supervision of an independent...

Cottonseed Drug Boosts Cancer Treatment in Mice

Gossypol, a drug refined from cottonseed oil, and previously tried and abandoned as a male contraceptive, could boost the effectiveness of treatment for prostate cancer and possibly other common cancers as well. New York /PSA Rising/ October 5, 2004 — Gossypol, a drug made from a toxic yellow pigment in cottonseed, for about a decade has been tested for use against prostate and other cancers. Gossypol in cotton is a...

The inhibitory effects of gossypol on human prosta...

Laboratory of Reproductive and Molecular Endocrinology, College of Veterinary Medicine, The Ohio State University, 1900 Coffey Road, Columbus, OH 43210, USA. BACKGROUND: Racemic gossypol [(+/-)-GP], a naturally occurring polyphenolic yellow pigment present in cottonseed products, inhibits in vitro proliferation of Dunning prostate cancer cells (MAT-LyLu), human prostate cancer cells derived from a bone marrow metastasis...

Producer-funded: Research would boost cottonseed u...

“We’re 80 percent of the way there, but that’s not enough. Our research is continuing in Texas, Oklahoma, and California.” Cottonseed may one day offer increased returns as a result of research efforts by Cotton Incorporated, says Bill Lalor, vice president of research for the producer-funded research/promotion organization. “Most growers and ginners don’t see the very extensive marketing...

Inhibition of human prostate cancer cells growth b...

Laboratory of Reproductive and Molecular Endocrinology, College of Veterinary Medicine, Ohio State University, Columbus 43210-1092, USA. Gossypol (GP), an antifertility agent in males, is also capable of inhibiting the proliferation of a wide range of cancer cells in vivo and in vitro. Thus, in this study we investigated the effect of GP on the growth of human androgen-independent prostate cancer cell line (PC3). The results...
Page 28 of 28« First...1020...2425262728